FDA approves drug to prevent graft versus host disease and decline in lung cancer deaths linked to screening.

by Kevin McLaughlin

A new program specializes in concerns of gay and bisexual men with prostate cancer, and Black women found to have a higher risk of lymphedema after breast cancer.

by Eric Fitzsimmons

Some cancer centers scrutinized for lack of pricing transparency, and an imaging drug helps surgeons better identify ovarian cancer with fluorescent lighting.

by Marci A. Landsmann

HPV vaccine rates are higher when teens decide, and colorectal cancer is on the rise in people under 50.

by Kevin McLaughlin

The U.S. Is behind the U.K. in preventing cervical cancer through HPV vaccination, and lack of health insurance impacts cancer screening in the unemployed.

by Eric Fitzsimmons

U.S. map spotlights industrial hot spots for cancer-causing air pollution, and surgery delays after initial treatment impact survival for some patients with locally advanced rectal cancer.

by Marci A. Landsmann

Patient expenses for cancer care exceed $21 billion in 2019, and the FDA introduces stringent requirements for breast implants.

by Kevin McLaughlin

Researchers suggest Black women should be screened for breast cancer at age 40, and a couple reflect on how a cancer diagnosis affected their adoption journey.

by Bradley Jones

FDA authorizes electronic cigarette for the first time, and a new survey explores marijuana use in breast cancer patients

by Eric Fitzsimmons

A study shows the cost of drugs that manage cancer-related symptoms adds up, and experts explore research at the AACR conference on cancer disparities.

by Marci A. Landsmann